Common Contracts
3 similar Underwriting Agreement contracts by Astria Therapeutics, Inc., Great Southern Bancorp, Inc., Mesa Laboratories Inc /Co
8,253,895 Shares of Common Stock Pre-Funded Warrants to Purchase 1,571,093 Shares of Common Stock and Common Stock Warrants to Purchase 7,368,738 Shares of Common Stock Astria Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2023 • Astria Therapeutics, Inc. • Pharmaceutical preparations • New York
75,000,000 Aggregate Principal Amount of Great Southern Bancorp, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • June 12th, 2020 • Great Southern Bancorp, Inc. • State commercial banks • New York
1.375% Convertible Senior Notes due 2025 Mesa Laboratories, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2019 • Mesa Laboratories Inc /Co • Industrial instruments for measurement, display, and control • New York
The information in this pricing term sheet supplements the preliminary prospectus supplement, dated August 6, 2019 (the “Common Stock Offering Preliminary Prospectus Supplement”), of Mesa Laboratories, Inc. (the “Issuer”), relating to an offering of common stock, no par value per share (the “Common Stock”), of the Issuer (the “Common Stock Offering”), and the preliminary prospectus supplement, dated August 6, 2019 (the “Notes Offering Preliminary Prospectus Supplement,” and, together with the Common Stock Offering Preliminary Prospectus Supplement, the “Preliminary Prospectus Supplements”), of the Issuer, relating to an offering of the Issuer’s 1.375% Convertible Senior Notes due 2025 (the “Notes Offering”). The information in this pricing term sheet supersedes the information in the Preliminary Prospectus Supplements to the extent inconsistent with the information in the Preliminary Prospectus Supplements. Terms used, but not defined, in this pricing term sheet have the respective mea
